US 11890281
SHP2 phosphatase inhibitors and methods of making and using the same
granted A61KA61K31/4985A61K45/06
Quick answer
US patent 11890281 (SHP2 phosphatase inhibitors and methods of making and using the same) held by Relay Therapeutics, Inc. expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relay Therapeutics, Inc.
- Grant date
- Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/4985, A61K45/06